KEEPS Mammographic Density And Breast Health Ancillary Study

NACompletedINTERVENTIONAL
Enrollment

517

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Mammographic DensityAbnormal Mammogram
Interventions
DRUG

CEE pill

Conjugated equine estrogens 0.45 mg/day

DRUG

Estradiol patch

Climara 50 mcg/day

DRUG

Active Progesterone

Prometrium (micronized progesterone USP encapsulated with peanut oil) 200 mg daily for the first 12 days of each month at bedtime

OTHER

Placebo tablet

Placebo tablet

OTHER

Placebo patch

placebo patch

OTHER

Placebo progesterone

placebo progesterone

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Kronos Longevity Research Institute

OTHER

collaborator

Albert Einstein College of Medicine

OTHER

collaborator

Columbia University

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

University of Utah

OTHER

collaborator

University of Washington

OTHER

collaborator

Yale University

OTHER

lead

Brigham and Women's Hospital

OTHER